150 Results for “William Lazonick”

The American Prospect highlights William Lazonick’s INET paper on US Pharma’s Financialized Business Model.

The Washington Post cites William Lazonick’s INET paper on shareholder value

“If companies continue to prioritize maximizing shareholder wealth at the expense of other key stakeholders, and at the expense of investing in innovation, then the Green New Deal could reinforce long-standing income and wealth inequities and the decline in innovation in the U.S. economy (for an important example, Bill Lazonick and Matt Hopkins document how maximizing shareholder value minimized the strategic national stockpile for ventilators and personal protective equipment).” —Lenore M Palladino

Pharmaceutical drugs are often a matter of life or death. It should be a prime objective of government policy to rid the industry of financialization.

“Nobody but those top corporate executives was really paying attention to share buybacks until the middle of the last decade, when University of Massachusetts economist William Lazonick wrote an article for the Harvard Business Review documenting the surprising and depressing fact that the companies that had belonged to the Fortune 500 during the previous decade had spent so much on share buybacks and dividends that the total was either equal to or actually exceeded their profits.”

Business school students are taught to extract resources instead of creating value.

Evidence sharply contradicts PhRMA’s contention that its member companies need unregulated drug prices to generate profits that they then reinvest in drug innovation.

Investment in productive capabilities provides the foundation for economic growth.

A nation must accumulate a high-tech knowledge base to prosper.

Industry lobbyists vehemently oppose Medicare drug price negotiations. However, physician-scientist Fred Ledley and economist William Lazonick debunk their arguments.

An Institute for New Economic Thinking Working Paper by William Lazonick and Matt Hopkins reveals that much reporting on executive pay relies on systems of measurement that underreport real compensation

Renewed interest by policymakers in the challenges of long-term slow economic growth highlights the importance of the Institute’s research

A comment on the Securities and Exchange Commission’s proposed rule “Share Repurchase Disclosure Modernization”

To strengthen the American semiconductor industry, Congress should condition additional funds on suspending stock buybacks

Background paper for a presentation to the Seattle University School of Law Berle IV Symposiun, “The Future of Financial/Securities Markets,” London June 14-15, 2012.